New faculty who joined VP&S in February and March include the chair of the Department of Radiology and the vice chair for basic research in the Department of Pediatrics.
New faculty who joined VP&S in recent months include a specialist in managing infections in immunocompromised patients and a researcher of precision cellular immunotherapies for autoimmunity.
New faculty who joined VP&S in November 2023 include two who have an interest in organ transplantation in children: One is a pediatric psychologist, the other a pediatric cardiologist.
Jeffrey Hall, Michael Rosbash, and Michael Young were awarded the 2017 Nobel Prize in Physiology or Medicine for their discoveries of molecular mechanisms controlling circadian rhythm.
Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
Immunotherapy expert Pawel Muranski speaks about the new CAR-T therapy for leukemia and his work to bring T cell therapies to patients with a wide range of cancers.